Literature DB >> 8980005

Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle.

K K Norton1, J Xu, D H Gutmann.   

Abstract

Vascular pathology is an underestimated complication of neurofibromatosis 1 (NF1). Manifestations include renovascular stenosis with associated hypertension, cerebrovascular occlusion, visceral ischaemia and aneurysms of smaller arteries. This is illustrated by a woman recently evaluated in our Neurofibromatosis Program who had multiple cerebrovascular and renovascular abnormalities. To determine the contribution of NF1 expression to NF1 vasculopathy, the expression of the NF1 gene product, neurofibromin, was examined in blood vessels. Neurofibromin was detected in the endothelial cell layer of rat cerebral vessels, renal arteries, and aorta by immunohistochemistry. Cultured bovine cerebral endothelial cells were found to express NF1 mRNA by RT-PCR and neurofibromin by Western immunoblotting and immunocytochemistry. Neurofibromin expression was also detected in the smooth muscle layer of the aorta but not of cerebral or renal vessels. The vascular abnormalities of NF1 are reviewed and possible pathogenesis with respect to neurofibromin expression is discussed. Copyright 1995 Academic Press, Inc.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8980005     DOI: 10.1006/nbdi.1995.0002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  19 in total

1.  Perioperative management of neurofibromatosis type 1.

Authors:  Charles J Fox; Samir Tomajian; Aaron J Kaye; Stephanie Russo; Jacqueline Volpi Abadie; Alan D Kaye
Journal:  Ochsner J       Date:  2012

Review 2.  Neurocutaneous Disorders for the Practicing Neurologist: a Focused Review.

Authors:  Anna Carolina Paiva Costa T Figueiredo; Nikolas Mata-Machado; Matthew McCoyd; José Biller
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

3.  The effect of semax and the C-terminal peptide PGP on expression of growth factor genes and receptors in rats under conditions of experimental cerebral ischemia.

Authors:  V G Dmitrieva; L V Dergunova; O V Povarova; V I Skvortsova; S A Limborskaya; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2008 Sep-Oct       Impact factor: 0.788

4.  Galenic dural arteriovenous fistula in neurofibromatosis type 1 treated with Onyx.

Authors:  Zongli Han; Yanli Du; Hui Qi
Journal:  Interv Neuroradiol       Date:  2019-05-31       Impact factor: 1.610

5.  Targeting neovascular pericytes in neurofibromatosis type 1.

Authors:  Ugur Ozerdem
Journal:  Angiogenesis       Date:  2005-05-09       Impact factor: 9.596

6.  Extracranial vertebral artery involvement in neurofibromatosis type I. Report of four cases and literature review.

Authors:  V M Pereira; S Geiprasert; T Krings; J G M P Caldas; F Toulgoat; A Ozanne; P Mercier; P L Lasjaunias
Journal:  Interv Neuroradiol       Date:  2008-02-01       Impact factor: 1.610

7.  Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI.

Authors:  Arun Padmanabhan; Jeong-Soo Lee; Fraz A Ismat; Min Min Lu; Nathan D Lawson; John P Kanki; A Thomas Look; Jonathan A Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

8.  Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.

Authors:  Bonnie Kaas; Thierry A G M Huisman; Aylin Tekes; Amanda Bergner; Jaishri O Blakeley; Lori C Jordan
Journal:  J Child Neurol       Date:  2012-07-25       Impact factor: 1.987

9.  Blood pressure and cardiovascular involvement in children with neurofibromatosis type1.

Authors:  Giuliana Lama; Luisa Graziano; Elvira Calabrese; Carolina Grassia; Pier Francesco Rambaldi; Fabrizio Cioce; Michele Adolfo Tedesco; Giovanni Di Salvo; Maria Esposito-Salsano
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

Review 10.  Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report.

Authors:  B Morris; S Partap; K Yeom; I C Gibbs; P G Fisher; A A King
Journal:  Neurology       Date:  2009-10-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.